Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion
Title:
Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion
Author:
Monica, Silvia La Minari, Roberta Cretella, Daniele Bonelli, Mara Fumarola, Claudia Cavazzoni, Andrea Galetti, Maricla Digiacomo, Graziana Riccardi, Federica Petronini, Pier Giorgio Tiseo, Marcello Alfieri, Roberta